Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2020

Open Access 01-12-2020 | Research article

Clinical presentation, evaluation and case management of primary empty sella syndrome: a retrospective analysis of 10-year single-center patient data

Authors: Aishah A. Ekhzaimy, Muhammad Mujammami, Shabana Tharkar, Manahel A. Alansary, Daad Al Otaibi

Published in: BMC Endocrine Disorders | Issue 1/2020

Login to get access

Abstract

Background

Primary Empty Sella (PES) syndrome is an increasingly common disorder, mostly diagnosed as an incidental finding during brain imaging scans. We intended to review the clinical management and hormonal profile of patients with PES.

Methods

The study included ten-year retrospective analysis of registry containing PES cases in the period 2007 to 2017, from a single tertiary care center. The keyword ‘primary empty sella’ was used to retrieve patient details from the radiology unit. The clinical and biochemical profile of PES patients was analyzed. Case management of PES patients and their rate of referral to endocrinologists was explored.

Results

The registry had 765 cases with a male: female ratio of 1:3.8 suggesting female predominance by almost four times. Although not significant, the onset of disease was earlier for males [Mean ± standard deviation (SD) (46.7 years ±17.3 vs 48.8 years±14.1), p = 0.110]. Almost 79% of the cases were found as an incidental finding during Magnetic Resonance Imaging. Of the total PES cases, only 20% were referred to the endocrinologists and the rest were handled by general physicians. Only 1–2.5% of the cases were evaluated for gonadal, growth and adrenal hormones by the general physicians. The hormonal evaluation by the endocrinologists was also found to be sub-optimal. Headache and visual disturbances were the most common presenting complaints followed by menstrual abnormalities. Endocrine abnormalities like thyroid dysfunction, hyperprolactinemia, hypogonadism and hypocortisolism were highly prevalent among those assessed.

Conclusion

There is a gross under-evaluation of hormonal assessment and minimal case-referral to Endocrinologists. PES is associated with varying degrees of hormonal dysfunction, and hence early assessment and management is needed. Establishing a standard protocol for diagnosis and case management is essential with the involvement of a multidisciplinary team consisting of endocrinologists, neurologists, primary care phys icians and ophthalmologists.
Literature
1.
go back to reference Stelmachowska-Banaś M, Czajka-Oraniec I, Zgliczyński W. Clinical and hormonal assessment of patients with empty Sella on MRI. Postępy Nauk Medycznych. 2014;12:814–8. Stelmachowska-Banaś M, Czajka-Oraniec I, Zgliczyński W. Clinical and hormonal assessment of patients with empty Sella on MRI. Postępy Nauk Medycznych. 2014;12:814–8.
2.
go back to reference Kaufman B. The “Empty” Sella Turcica - A Manifestation of the Interstellar Subarachnoid Space. Radiology. 1968;90:931.CrossRef Kaufman B. The “Empty” Sella Turcica - A Manifestation of the Interstellar Subarachnoid Space. Radiology. 1968;90:931.CrossRef
3.
go back to reference Debnath J, Ravikumar R, Sharma V, Senger KP, Maurya V, Singh G, Sharma P, Khera A, Singh A. Empty sella’ on routine MRI studies: An incidental finding or otherwise? Med J Armed Forces India. 2016;72:33–7.CrossRef Debnath J, Ravikumar R, Sharma V, Senger KP, Maurya V, Singh G, Sharma P, Khera A, Singh A. Empty sella’ on routine MRI studies: An incidental finding or otherwise? Med J Armed Forces India. 2016;72:33–7.CrossRef
4.
go back to reference Jordan RM, Kendall JW, Kerber CW. Primary empty Sella syndrome analysis of the clinical characteristics, radiographic features, pituitary function and cerebrospinal fluid Adenohypophysial hormone concentrations. Am J of Med. 1977;62:569–81.CrossRef Jordan RM, Kendall JW, Kerber CW. Primary empty Sella syndrome analysis of the clinical characteristics, radiographic features, pituitary function and cerebrospinal fluid Adenohypophysial hormone concentrations. Am J of Med. 1977;62:569–81.CrossRef
5.
go back to reference Foresti M, Guidali A, Susanna P. Primary empty Sella. Incidence in 500 asymptomatic subjects examined with magnetic resonance. Radiol Med. 1991;81(6):803–7.PubMed Foresti M, Guidali A, Susanna P. Primary empty Sella. Incidence in 500 asymptomatic subjects examined with magnetic resonance. Radiol Med. 1991;81(6):803–7.PubMed
6.
go back to reference Chiloiro S, Giampietro A, Bianchi A, Tartaglione T, Capobianco A, Anile C, De Marinis L. Primary empty Sella: a comprehensive review. Eur J Endocrinol. 2017;177:275–85.CrossRef Chiloiro S, Giampietro A, Bianchi A, Tartaglione T, Capobianco A, Anile C, De Marinis L. Primary empty Sella: a comprehensive review. Eur J Endocrinol. 2017;177:275–85.CrossRef
8.
go back to reference Ambrosi B, Faglia G. How much of our pituitary is really necessary? J Endocrin Invest. 2002;25:812.CrossRef Ambrosi B, Faglia G. How much of our pituitary is really necessary? J Endocrin Invest. 2002;25:812.CrossRef
9.
go back to reference Guitelman M, Garcia Basavilbaso N, Vitale M, Chervin A, Katz D, et al. Primary empty Sella (PES): a review of 175 cases. Pituitary. 2013;16:270–4.CrossRef Guitelman M, Garcia Basavilbaso N, Vitale M, Chervin A, Katz D, et al. Primary empty Sella (PES): a review of 175 cases. Pituitary. 2013;16:270–4.CrossRef
10.
go back to reference Gallardo E, Schachter D, Caceres E, Becker P, Colin E, Martinez C, Henriquez C. The empty Sella: results of treatment in 76 successive cases and high frequency of endocrine and neurological disturbances. Clin Endocrinol. 1992;37:529–33.CrossRef Gallardo E, Schachter D, Caceres E, Becker P, Colin E, Martinez C, Henriquez C. The empty Sella: results of treatment in 76 successive cases and high frequency of endocrine and neurological disturbances. Clin Endocrinol. 1992;37:529–33.CrossRef
11.
go back to reference Galvin JA, Van Stavern GP. Clinical characterization of idiopathic intracranial hypertension at the Detroit medical center. J Neurol Sci. 2004;223:157–60.CrossRef Galvin JA, Van Stavern GP. Clinical characterization of idiopathic intracranial hypertension at the Detroit medical center. J Neurol Sci. 2004;223:157–60.CrossRef
12.
go back to reference Saindane AM, Lim PP, Aiken A, Chen Z, Hudgin PA. Factors determining the clinical significance of an “empty” Sella Turcica. Neuroradiology. 2013;200(5):1125–31. Saindane AM, Lim PP, Aiken A, Chen Z, Hudgin PA. Factors determining the clinical significance of an “empty” Sella Turcica. Neuroradiology. 2013;200(5):1125–31.
13.
go back to reference Agid R, Farb RI, Willinsky RA, Mikulis DJ, Tomlinson G. Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology. 2006;48:521–7.CrossRef Agid R, Farb RI, Willinsky RA, Mikulis DJ, Tomlinson G. Idiopathic intracranial hypertension: the validity of cross-sectional neuroimaging signs. Neuroradiology. 2006;48:521–7.CrossRef
14.
go back to reference Maira G, Anile C, Mangiola A. Primary empty Sella syndrome in a series of 142 patients. J Neurosurg. 2005;103:831–6.CrossRef Maira G, Anile C, Mangiola A. Primary empty Sella syndrome in a series of 142 patients. J Neurosurg. 2005;103:831–6.CrossRef
15.
go back to reference Brisman R, Hughes JE, Holub DA. Endocrine function in nineteen patients with empty Sella syndrome. J Clin Endocrinol Metab. 1972;34(3):570–3.CrossRef Brisman R, Hughes JE, Holub DA. Endocrine function in nineteen patients with empty Sella syndrome. J Clin Endocrinol Metab. 1972;34(3):570–3.CrossRef
16.
go back to reference Del Monte P, Foppiani L, Cafferata C, Marugo A, Bernasconi D. Primary “empty sella” in adults: endocrine findings. Endocr J. 2006;53(6):803–9.CrossRef Del Monte P, Foppiani L, Cafferata C, Marugo A, Bernasconi D. Primary “empty sella” in adults: endocrine findings. Endocr J. 2006;53(6):803–9.CrossRef
17.
go back to reference Gasperi M, Aimaretti G, Cecconi E, et al. Impairment of GH secretion in adults with primary empty Sella. J Endocrinol Investig. 2002;25(4):329–33.CrossRef Gasperi M, Aimaretti G, Cecconi E, et al. Impairment of GH secretion in adults with primary empty Sella. J Endocrinol Investig. 2002;25(4):329–33.CrossRef
18.
go back to reference Ghatnatti V, Sarma D, Saikia U. Empty sella syndrome – beyond being an incidental finding. Indian J Endocrinol Metab. 2012;16:S321–3.CrossRef Ghatnatti V, Sarma D, Saikia U. Empty sella syndrome – beyond being an incidental finding. Indian J Endocrinol Metab. 2012;16:S321–3.CrossRef
19.
go back to reference Poggi M, Monti S, Lauri C, Pascucci C, Bisogni V, Toscano V. Primary empty Sella and GH deficiency: prevalence and clinical implications. Ann Ist Super Sanita. 2012;48(1):91–6.PubMed Poggi M, Monti S, Lauri C, Pascucci C, Bisogni V, Toscano V. Primary empty Sella and GH deficiency: prevalence and clinical implications. Ann Ist Super Sanita. 2012;48(1):91–6.PubMed
20.
go back to reference Gharib H, Frey HM, Laws ER Jr, Randall RV, Scheithauer BW. Coexistent primary empty sella syndrome and hyperprolactinemia. Arch Intern Med. 1983;143:1383–6.CrossRef Gharib H, Frey HM, Laws ER Jr, Randall RV, Scheithauer BW. Coexistent primary empty sella syndrome and hyperprolactinemia. Arch Intern Med. 1983;143:1383–6.CrossRef
21.
go back to reference García-Centeno R, Suárez-Llanos JP, Fernández-Fernández E, Andía-Melero V, Sánchez P, Jara-Albarrán A. Empty sella and primary autoimmune hypothyroidism. Clin Exp Med. 2010;10(2):129–34.CrossRef García-Centeno R, Suárez-Llanos JP, Fernández-Fernández E, Andía-Melero V, Sánchez P, Jara-Albarrán A. Empty sella and primary autoimmune hypothyroidism. Clin Exp Med. 2010;10(2):129–34.CrossRef
Metadata
Title
Clinical presentation, evaluation and case management of primary empty sella syndrome: a retrospective analysis of 10-year single-center patient data
Authors
Aishah A. Ekhzaimy
Muhammad Mujammami
Shabana Tharkar
Manahel A. Alansary
Daad Al Otaibi
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2020
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-00621-5

Other articles of this Issue 1/2020

BMC Endocrine Disorders 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.